How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Breathing Anesthesia Achine for Experimental Animals Market
- By Animal Type: Rodents (Mice, Rats), Non-human Primates, Rabbits, Canines, Felines
- By Anesthesia Delivery Method: Vaporizer-based Systems, Precision Vaporizer Systems, Non-rebreathing Systems, Rebreathing Systems
- By Application: Pharmacological Research, Toxicology Studies, Surgical Procedures, Physiological Monitoring, Behavioral Studies
- By End User: Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Veterinary Hospitals and Clinics
- By Product Features: Integrated Gas Scavenging Systems, Multi-animal Anesthesia Capability, Digital Monitoring and Control, Portable and Compact Designs
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Rodents (Mice, Rats) leads By Animal Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.180 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.188 →
Full report · locked preview
Everything inside the Breathing Anesthesia Achine for Experimental Animals Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Animal Type 5
Anesthesia Delivery Method 4
Application 5
End User 4
Product Features 4
Companies profiled
Harvard Apparatus
Kent Scientific Corporation
VetEquip Inc.
DRE Veterinary
TSE Systems GmbH
Instech Laboratories Inc.
CWE Inc.
Scintica Instrumentation
Panlab Harvard Apparatus
LEICA Microsystems
Bioseb
Med Associates Inc.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Harvard Apparatus
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Kent Scientific Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →VetEquip Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →DRE Veterinary
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →TSE Systems GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Instech Laboratories Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →CWE Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Scintica Instrumentation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Panlab Harvard Apparatus
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →LEICA Microsystems
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Bioseb
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Med Associates Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Anesthesia Systems Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →SomnoSuite by Kent Scientific
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Indus Instruments
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,744M by 2033 · 9.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Rodents (Mice, Rats)53.5
- Non-human Primates7.6
- Rabbits14.9
- Canines16.3
- Felines7.7
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$928.8M → $1,849M · 9.0%
Europe$647.3M → $1,211M · 8.1%
Asia Pacific$591.0M → $1,220M · 9.5%
Latin America$365.9M → $673.1M · 7.9%
Middle East and Africa$281.4M → $617.8M · 10.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.272026
9.292027
9.302028
9.322029
9.332030
9.352031
9.352032
9.362033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Harvard Apparatus10.3
- Kent Scientific Corporation24.5
- VetEquip Inc.6.2
- DRE Veterinary11.1
- TSE Systems GmbH11.9
- Instech Laboratories Inc.8.0
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Animal Type14.9%
Anesthesia Delivery Method17.0%
Application24.9%
End User12.4%
Product Features30.8%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.2
- Europe21.7
- Asia Pacific21.9
- Latin America12.1
- Middle East and Africa11.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Harvard Apparatus | 84 | 75 | 77 | 92 | 75 | 90 | 82 |
| Kent Scientific Corporation | 75 | 84 | 86 | 91 | 76 | 84 | 83 |
| VetEquip Inc. | 86 | 66 | 83 | 83 | 73 | 86 | 80 |
| DRE Veterinary | 69 | 80 | 69 | 69 | 57 | 78 | 70 |
| TSE Systems GmbH | 76 | 55 | 64 | 75 | 51 | 68 | 65 |
| Instech Laboratories Inc. | 60 | 51 | 58 | 67 | 71 | 62 | 62 |
| CWE Inc. | 54 | 63 | 62 | 42 | 45 | 53 | 53 |
| Scintica Instrumentation | 49 | 58 | 41 | 54 | 45 | 47 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Harvard Apparatus
- Kent Scientific Corporation
- VetEquip Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Harvard Apparatus | ✓ | ◐ | ◐ | ◐ | ✓ | ◐ |
| Kent Scientific Corporation | ✓ | ◐ | ✓ | ✓ | ◐ | ✓ |
| VetEquip Inc. | ✓ | − | ◐ | ✓ | ◐ | ◐ |
| DRE Veterinary | ◐ | ✓ | ✓ | − | ◐ | ✓ |
| TSE Systems GmbH | ◐ | ◐ | ✓ | ✓ | − | ◐ |
| Instech Laboratories Inc. | ◐ | − | ◐ | − | ◐ | ◐ |
| CWE Inc. | − | ◐ | − | ◐ | ◐ | − |
| Scintica Instrumentation | − | ◐ | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Kent Scientific Corporation83
2Harvard Apparatus82
3VetEquip Inc.80
4DRE Veterinary70
5TSE Systems GmbH65
6Instech Laboratories Inc.62
7CWE Inc.53
8Scintica Instrumentation49
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Harvard ApparatusKent Scientific CorporationVetEquip Inc.
Challenger1
Strong scale, closing on the leaders.
DRE Veterinary
Contender2
Focused players with pockets of strength.
TSE Systems GmbHInstech Laboratories Inc.
Niche2
Specialists in a single segment or region.
CWE Inc.Scintica Instrumentation
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Animal Type in North America, then scale across Breathing Anesthesia Achine for Experimental Animals Market — a $379M beachhead inside a $6.58B market.
Beachhead (SOM)$379Mobtainable near-term
Serviceable (SAM)$2.33Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Rodents (Mice, Rats)
Best fit — highest urgency & budget in Animal Type.
Economic buyer79 fit
Non-human Primates
Strong fit — clear ROI and a fast path to value.
End user68 fit
Rabbits
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Animal Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Anesthesia Delivery Method & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel30%
Digital / self-serve20%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Animal Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Breathing Anesthesia Achine for Experimental Animals Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified24%
Evaluation13%
Closed-won6%
$19.0KCAC
$95KLTV
5.0:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Breathing Anesthesia Achine for Experimental Animals Market is a high-growth opportunity — $1.78B by 2033, compounding at 11.3%.
TAM · 2025$755Mtoday
TAM · 2033$1.78Bforecast
CAGR11.3%2027–2033
Cumulative$10.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.78BTotal addressable market
SAM$723MServiceable available market
SOM$144MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.3% CAGR
Demand compounds through 2033, outpacing GDP across Animal Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Animal Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.78BLarge & growingTAM by 2033 at 11.3% CAGR
$723MServiceable nowreachable with today’s model
$144MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.39BBear7.4% CAGR
$1.78BBase11.3% CAGR
$2.28BBull14.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Anesthesia Delivery Method optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Breathing Anesthesia Achine for Experimental Animals Market — a $5.79B market by 2033. Plan: grow share from 11.8% to 18.3%.
Market size · 2033$5.79Btotal addressable
Market CAGR8.2%2027–2033
Target share18.3%from 11.8% today
Revenue ambition$1.06Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 11.8% | 18.3% | On track |
| Revenue | $638M | $1.06B | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 34.2% | 42.4% | On track |
| Customer retention | 90.8% | 93.3% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Animal Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Anesthesia Delivery Method capability
A defensible second engine — invest in Anesthesia Delivery Method to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Animal Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Anesthesia Delivery Method
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $144M capacity & capability investment
- Greenlight bolt-on M&A in Anesthesia Delivery Method
- Authorise North America expansion plan
- Fund R&D program for Animal Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossBehind
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Breathing Anesthesia Achine for Experimental Animals Market conversation — a $2.15B market you can size, segment and defend in minutes.
Market size · 2033$2.15Btotal opportunity
Growth9.0%CAGR to 2033
Addressable buyers1,241+accounts in scope
Typical ROI7.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Animal Type
Goal Grow share in Animal Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.4×return on cost, year one
< 3 mopayback period
$59K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Harvard ApparatusKent Scientific CorporationVetEquip Inc.DRE VeterinaryTSE Systems GmbHInstech Laboratories Inc.CWE Inc.Scintica Instrumentation+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Breathing Anesthesia Achine for Experimental Animals Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Breathing Anesthesia Achine for Experimental Animals Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Breathing Anesthesia Machine Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportBreathing Circuit Filters Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportBreathing Disorders and Treatment Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportBreathing Filter Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportBreathing Machine Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportBreathing Paper Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportBreathing Trainers Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportBreeding Horses Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportBrew and Beverage Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportBrewed Beverages Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportBrewer Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportBrewing Machinery Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.